ARAMA SONUÇLARI

Toplam 10 adet sonuçtan 10 tanesi görüntülenmektedir.

A drug repurposing study to target bacterial ribosome decoding center with molecular docking and molecular dynamics simulations

Lisansüstü Eğitim Enstitüsü, İstanbul Teknik Üniversitesi, 2024

BERİL ATEŞ ULUTÜRK

Ayşe Özge Kürkçüoğlu Levitas Tez Yüksek Lisans Tamamlandı

A Breakthrough in the In-Silico Drug Repurposing of Baicalein and β-Sitosterol for the Suppression of Pancreatic Cancer

Journal of Pancreas, Vol. 24, No. 59, Ocak 2024, s. 1-6, ISSN: 1590-8577

AĞAR SOYKAN,AKKURT BARBAROS

Barbaros Akkurt Özgün Makale

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study

MOLECULAR INFORMATICS, Vol. 41, No. 2, Şubat 2022, ISSN: 1868-1743

DURDAĞI SERDAR, ORHAN MÜGE DİDEM, AKSOYDAN BUSECAN, CALİS SEYMA, DOĞAN BERNA, ŞAHİN KADER, SHAHRAKİ AİDA, IYİSON NECLA BİRGÜL, AVŞAR TİMUÇİN

Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing

STRUCTURE, Vol. 29, No. 12, Aralık 2021, s. 1382, ISSN: 0969-2126

DURDAĞI SERDAR, DOĞAN BERNA, DEMİRCİ HASAN

Drug repurposing for the S. aureus pyruvate kinase allosteric sites

EMBO Workshop: Advances and Challenges in Biomolecular Simulations, 18 Ekim 2021

YÜCE MERVE, SARICA ZEHRA, ATEŞ BERİL, KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE

Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction

Journal of the Turkish Chemical Society Section A: Chemistry, Vol. 8, No. 3, Ağustos 2021, s. 933-940, ISSN: 2149-0120

BADAY SEFER

Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, Vol. 89, No. 11, Ocak 2021, s. 1425-1441, ISSN: 0887-3585

YÜCE MERVE, ÇİÇEK ERDEM, DAĞ ASLIHAN BAŞAK, KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE, SUNGUR FETHİYE AYLİN

Drug repurposing for the S. aureus pyruvate kinase allosteric sites

EMBO Workshop-Advances and Challenges in Biomolecular Simulations, 18 Ekim 2021

YÜCE MERVE, KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE, ATEŞ BERİL, SARICA ZEHRA

Merve Yüce Özet Bildiri

Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease

Proteins: Structure, Function, and Bioinformatics, Vol. 89, No. 11, Kasım 2021, s. 1425-1441, ISSN: 0887-3585

YÜCE MERVE, ÇİÇEK ERDEM, İNAN TUĞÇE, DAĞ ASLIHAN BAŞAK, KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE, SUNGUR FETHİYE AYLİN

Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, Vol. 89, No. 11, Ocak 2021, s. 1425-1441, ISSN: 0887-3585

YÜCE MERVE, ÇİÇEK ERDEM, DAĞ ASLIHAN BAŞAK, KÜRKÇÜOĞLU LEVİTAS AYŞE ÖZGE, SUNGUR FETHİYE AYLİN